. Author manuscript; available in PMC: 2017 Mar 1.

Published in final edited form as: J Allergy Clin Immunol. 2015 Oct 30;137(3):767–73.e6. doi: 10.1016/j.jaci.2015.05.053

Table 3.

Sputum FXIII mRNA level correlates with pulmonary functions in asthma, n=56

	n	FXIII no adjustment		FXIII age-adjusted
	n	r	p-value	r	p-value
% reversibility FEV₁ PP	56	0.45	0.0005	0.39	0.003
FEV₁/FVC PP	56	− 0.42	0.001	− 0.35	0.008
RV/TLC PP	51	0.37	0.008	0.36	0.01
FEV₁/FVCMX PP	56	− 0.30	0.02	− 0.21	0.11
FEV₁ PP	56	− 0.30	0.03	− 0.20	0.15

% reversibility; reversibility after β-agonist; FEV₁, force expiratory volume in 1 second; FVC, force vital capacity; MX, maximum after β-agonist; PP, percentage predicted; RV, residual volume; TLC, total lung capacity.